Winshine Science Co (HKSE:00209) Short-Term Debt & Capital Lease Obligation : HK$242.1 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Winshine Science Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$242.1 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Winshine Science Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1.9 Mil.

Winshine Science Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Winshine Science Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co Short-Term Debt & Capital Lease Obligation Chart

Winshine Science Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

212.90

235.27

268.34

192.91

242.10

Winshine Science Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															268.34	255.28	192.91	248.12	242.10

Winshine Science Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Winshine Science Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Winshine Science Co (HKSE:00209) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG

Website

http://www.winshine.com

Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.

Executives

Wang Honggang	2101 Beneficial owner
U Credit (hk) Limited	2106 Person having a security interest in shares
Csc Holdings Limited	2106 Person having a security interest in shares
Hurray Talent Investment Development Limited	2101 Beneficial owner
Li Zhonghai	2201 Interest of corporation controlled by you
Liu Lian	2201 Interest of corporation controlled by you
Richsun Investment Development Limited	2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited	2101 Beneficial owner
Jiang Qinghui	2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited")	2106 Person having a security interest in shares
China Strategic Holdings Limited	2106 Person having a security interest in shares
Shen Jia	2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines